scispace - formally typeset
Open AccessJournal ArticleDOI

Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors' and Longitudinal ‘Targets'

Reads0
Chats0
TLDR
In this article, the leukocyte mRNA expression levels of genes belonging to glucocorticoid receptor (GR) function (FKBP-4, FKBP-5, and GR), inflammatory cytokines (interleukin (IL)-1a, IL-1b), IL-6 and IL-7), macrophage inhibiting factor (MIF), and tumor necrosis factor (TNF)-a), were tested before and after 8 weeks of treatment with escitalopram or nortriptyline, as part of the Genome-
About
This article is published in Neuropsychopharmacology.The article was published on 2013-02-01 and is currently open access. It has received 342 citations till now. The article focuses on the topics: Proinflammatory cytokine.

read more

Citations
More filters
Journal ArticleDOI

The role of inflammation in depression: from evolutionary imperative to modern treatment target

TL;DR: Current understanding of the mechanisms by which the innate and adaptive immune systems interact with neurotransmitters and neurocircuits to influence the risk for depression are detailed.
Journal ArticleDOI

Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications

TL;DR: This review explores the idea that specific gene polymorphisms and neurotransmitter systems can confer protection from or vulnerability to specific symptom dimensions of cytokine-related depression and potential therapeutic strategies that target inflammatory cytokine signaling.
References
More filters
Journal ArticleDOI

p11 is up-regulated in the forebrain of stressed rats by glucocorticoid acting via two specific glucocorticoid response elements in the p11 promoter.

TL;DR: It is demonstrated that inescapable tail shock increased both prefrontal cortical p11 mRNA levels and plasma corticosterone levels in rats and it was shown that p 11 mRNA levels were increased in postmortem prefrontal cortical tissue of patients with PTSD.
Journal ArticleDOI

The Neuropeptide VGF Is Reduced in Human Bipolar Postmortem Brain and Contributes to Some of the Behavioral and Molecular Effects of Lithium

TL;DR: It is demonstrated using in situ hybridization that VGF is downregulated in bipolar disorder in the CA region of the hippocampus and Brodmann's area 9 of the prefrontal cortex and is necessary for the induction of mitogen-activated protein kinase and Akt by LiCl, thus lending insight into the molecular mechanisms underlying the actions of VGF.
Journal ArticleDOI

Biomarkers predicting treatment outcome in depression: what is clinically significant?

TL;DR: This report provides guidance on assessing clinical significance of biomarkers predictive of outcome in depression treatment and recommends a number needed to assess of three suggests that with this effect size, a biomarker will significantly improve the prediction of outcomes in one out of every three patients assessed.
Journal ArticleDOI

The prednisolone suppression test in depression: Dose—response and changes with antidepressant treatment

TL;DR: The response to prednisolone is similar in depressed patients and controls at different doses of prednisOLone, and does not change with symptomatic improvement, in contrast with findings using other measures of hypothalamic-pituitary-adrenal axis function, such as basal cortisol levels or the response to dexamethasone.
Journal ArticleDOI

Serum brain-derived neurotrophic factor and glucocorticoid receptor levels in lymphocytes as markers of antidepressant response in major depressive patients: A pilot study

TL;DR: It is concluded that levels of BDNF in serum and GR levels in lymphocytes may represent biomarkers that could be used to predict responses to venlafaxine treatment, and levels of phospho-CREB (pCREB) did not affect levels of pCREB.
Related Papers (5)